N. Keske Et Al. , "In silico drug screen reveals potential competitive MTHFR inhibitors for clinical repurposing," JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS , vol.41, no.21, pp.11818-11831, 2023
Keske, N. Et Al. 2023. In silico drug screen reveals potential competitive MTHFR inhibitors for clinical repurposing. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS , vol.41, no.21 , 11818-11831.
Keske, N., Ozay, B., Tukel, E. Y., Mentes, M., & Yandim, C., (2023). In silico drug screen reveals potential competitive MTHFR inhibitors for clinical repurposing. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS , vol.41, no.21, 11818-11831.
Keske, Nazligul Et Al. "In silico drug screen reveals potential competitive MTHFR inhibitors for clinical repurposing," JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS , vol.41, no.21, 11818-11831, 2023
Keske, Nazligul Et Al. "In silico drug screen reveals potential competitive MTHFR inhibitors for clinical repurposing." JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS , vol.41, no.21, pp.11818-11831, 2023
Keske, N. Et Al. (2023) . "In silico drug screen reveals potential competitive MTHFR inhibitors for clinical repurposing." JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS , vol.41, no.21, pp.11818-11831.
@article{article, author={Nazligul Keske Et Al. }, title={In silico drug screen reveals potential competitive MTHFR inhibitors for clinical repurposing}, journal={JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS}, year=2023, pages={11818-11831} }